🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kamrine E. Poels

Pfizer (United States)

ORCID: 0000-0002-7220-2213

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer”.

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-23912-4

N/A

1.1DataRank · unranked

34 citations

Adam J. Schoenfeld, Alex Makhnin, Yosef Y. Tobi, Yuli Wang, Heidie Frisco Cabanos +10 more

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

Cancer Research(2020)10.1158/0008-5472.can-19-3819

N/A

0DataRank · unranked

60 citations

Alexis Guernet, Maria Emanuela Cuomo, Kamrine E. Poels, Iris K. van Alderwerelt van Rosenburgh, Amy Nagelberg +19 more

Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia

iScience(2021)10.1016/j.isci.2021.102651

N/A

0DataRank · unranked

9 citations

Kamrine E. Poels, Cong-Hui Yao, Kimihito C. Kawabata, Gongwei Wu, Cihangir Duy +17 more

Roadmap on plasticity and epigenetics in cancer

Physical Biology(2022)10.1088/1478-3975/ac4ee2

N/A

0DataRank · unranked

24 citations

David Basanta, Russell C. Rockne, Carly Strelez, Curran Shah, Kimya Ghaffarian +19 more